Effective January 16, 2018, new regulations were put in place that restrict financial relationships between pharmaceutical manufacturers and New Jersey licensed providers, including physicians, podiatrists, physician assistants, advanced practice nurses, dentists, and optometrists (collectively referred to as “prescribers”).
Click Here to read entire Legal Alert.
* * * * *
|About Garfunkel Wild, P.C.|
Garfunkel Wild, P.C. was founded in 1980 with a single purpose in mind: to become a pre-eminent health care law firm attending to the unique business and legal needs of its clients. Since then, the firm has grown to over 70 attorneys devoted to addressing the complex legal, regulatory, business and financial needs of its diverse clients.
If you would like to receive Legal Alert mailings from Garfunkel Wild, P.C. electronically in the future, or if you would like to be removed from the mailing list, please contact us at (516) 393-2200 or eMail us at email@example.com. You may also visit the Firm’s website.
THIS MATERIAL IS INTENDED AS INFORMATIONAL ONLY AND THE CONTENT SHOULD NOT BE CONSTRUED AS LEGAL ADVICE. READERS SHOULD NOT ACT UPON INFORMATION IN THIS MATERIAL WITHOUT FIRST SEEKING PROFESSIONAL ADVICE.